[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Abeona Therapeutics (ABEO)

Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 341,115
  • Shares Outstanding, K 56,995
  • Annual Sales, $ 5,820 K
  • Annual Income, $ 71,180 K
  • EBIT $ -93 M
  • EBITDA $ -89 M
  • 60-Month Beta 1.35
  • Price/Sales 62.14
  • Price/Cash Flow N/A
  • Price/Book 2.49

Options Overview Details

View History
  • Implied Volatility 72.73% (-14.08%)
  • Historical Volatility 69.53%
  • IV Percentile 2%
  • IV Rank 1.35%
  • IV High 1,170.59% on 01/14/26
  • IV Low 57.72% on 08/19/25
  • Expected Move (DTE 5) 0.34 (5.68%)
  • Put/Call Vol Ratio 0.49
  • Today's Volume 560
  • Volume Avg (30-Day) 688
  • Put/Call OI Ratio 0.27
  • Today's Open Interest 21,364
  • Open Int (30-Day) 18,072
  • Expected Range 5.65 to 6.33

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.14
  • Number of Estimates 4
  • High Estimate $-0.01
  • Low Estimate $-0.26
  • Prior Year $-0.10
  • Growth Rate Est. (year over year) -40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.82 +2.84%
on 08/14/26
7.65 -21.76%
on 08/11/26
-1.07 (-15.23%)
since 07/14/26
3-Month
5.08 +17.81%
on 05/19/26
7.65 -21.76%
on 08/11/26
+0.39 (+6.88%)
since 05/14/26
52-Week
4.00 +49.63%
on 11/07/25
7.65 -21.76%
on 08/11/26
-1.24 (-17.22%)
since 08/14/25

Most Recent Stories

More News
Abeona Therapeutics: Q2 Earnings Snapshot

Abeona Therapeutics: Q2 Earnings Snapshot

ABEO : 5.99 (-5.67%)
Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update

- Q2 net ZEVASKYN® revenue increased 31% quarter-over-quarter to $11.4 million – - Five patients treated with ZEVASKYN in Q2 2026 and three treatments in Q3 2026 to-date; since launch, 12 treatments...

ABEO : 5.99 (-5.67%)
Abeona's Path to Monthly Profitability Hinges on Tomorrow's Treatment Numbers, If They Materialize

Barchart Research What to Expect from ABEO Earnings ABEO Generated August 12, 2026 Current Price $7.46 EPS Estimate $$-0.23 Consensus Rating Strong Buy Average Move 7.01% Abeona's Path to Monthly Profitability...

ABEO : 5.99 (-5.67%)
Abeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026

CLEVELAND, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that the Company will host a conference call on Thursday, August 13, 2026 at 8:30 a.m. ET to discuss...

ABEO : 5.99 (-5.67%)
CMS Grants New Technology Add-On Payment (NTAP) Status for ZEVASKYN®

CLEVELAND, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases, today announced...

ABEO : 5.99 (-5.67%)
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CLEVELAND, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards...

ABEO : 5.99 (-5.67%)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Abeona Therapeutics Inc. (NASDAQ: ABEO)

NEW YORK , July 27, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Abeona Therapeutics Inc. (NASDAQ: ABEO) on behalf of the company's shareholders. The investigation...

ABEO : 5.99 (-5.67%)
Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®

CLEVELAND, July 21, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases, today announced...

ABEO : 5.99 (-5.67%)
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CLEVELAND, July 01, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards...

ABEO : 5.99 (-5.67%)
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CLEVELAND, June 01, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards...

ABEO : 5.99 (-5.67%)

Business Summary

Abeona Therapeutics, Inc. is engaged in developing and delivering gene therapy and plasma-based products for rare diseases. Abeona Therapeutics Inc., formerly known as PlasmaTech Biopharmaceuticals, Inc., is based in Dallas, United States.

See More

Key Turning Points

3rd Resistance Point 6.71
2nd Resistance Point 6.50
1st Resistance Point 6.24
Last Price 5.99
1st Support Level 5.77
2nd Support Level 5.56
3rd Support Level 5.30

See More

52-Week High 7.65
Fibonacci 61.8% 6.26
Last Price 5.99
Fibonacci 50% 5.82
Fibonacci 38.2% 5.39
52-Week Low 4.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.